$675.79
-18.85-2.71%
At close: -
$674.00
-1.79-0.26%
After Hours: 5:24 PM EDT
Comments
Loading...
Latest news for Regeneron Pharmaceuticals (NASDAQ:REGN) Stock
Regeneron Pharmaceuticals Stock (NASDAQ: REGN)
Categories: All
Friday, January 24, 2025
Thursday, January 16, 2025
Tuesday, January 14, 2025
Monday, January 13, 2025
Friday, January 10, 2025
Thursday, January 09, 2025
Wednesday, January 08, 2025
Tuesday, January 07, 2025
Monday, January 06, 2025
Thursday, January 02, 2025
Monday, December 23, 2024
Sunday, December 22, 2024
Thursday, December 19, 2024
Tuesday, December 17, 2024
- Regeneron Pharmaceuticals shares are trading ...
- Regeneron's Best-Selling Eye Drug Eylea's Higher Dose Formulation Meets Primary Goal In Another Form Of Retinal Disease Study
- Stocks Slip As Strong November Retail Sales Raise Concerns Over 2025 Fed Rate Cuts
- What 25 Analyst Ratings Have To Say About Regeneron Pharmaceuticals
- Regeneron Says Primary Endpoint Was Met In Ph...